MNPR vs. ^GSPC
Compare and contrast key facts about Monopar Therapeutics Inc. (MNPR) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MNPR or ^GSPC.
Correlation
The correlation between MNPR and ^GSPC is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MNPR vs. ^GSPC - Performance Comparison
Key characteristics
MNPR:
1.75
^GSPC:
1.62
MNPR:
8.49
^GSPC:
2.20
MNPR:
2.15
^GSPC:
1.30
MNPR:
11.22
^GSPC:
2.46
MNPR:
26.18
^GSPC:
10.01
MNPR:
42.14%
^GSPC:
2.08%
MNPR:
629.67%
^GSPC:
12.88%
MNPR:
-98.93%
^GSPC:
-56.78%
MNPR:
-70.19%
^GSPC:
-2.13%
Returns By Period
In the year-to-date period, MNPR achieves a 82.95% return, which is significantly higher than ^GSPC's 2.24% return.
MNPR
82.95%
19.54%
1,466.15%
618.75%
-4.16%
N/A
^GSPC
2.24%
-1.20%
6.72%
18.21%
12.53%
11.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MNPR vs. ^GSPC — Risk-Adjusted Performance Rank
MNPR
^GSPC
MNPR vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Monopar Therapeutics Inc. (MNPR) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
MNPR vs. ^GSPC - Drawdown Comparison
The maximum MNPR drawdown since its inception was -98.93%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for MNPR and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
MNPR vs. ^GSPC - Volatility Comparison
Monopar Therapeutics Inc. (MNPR) has a higher volatility of 42.88% compared to S&P 500 (^GSPC) at 3.43%. This indicates that MNPR's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.